Watanabe Y, Hara Y, Tamagawa M, Nakaya H
Department of Pharmacology, Chiba University School of Medicine, Japan.
J Pharmacol Exp Ther. 1996 Nov;279(2):617-24.
It is well known that amiodarone is effective for the treatment of atrial fibrillation. However, effects of amiodarone on the muscarinic acetylcholine receptor-operated K+ current (IK.ACh), which plays an important role in the repolarization of atrial action potential, have not been evaluated. This study was undertaken to determine whether amiodarone inhibits the acetyl-choline-sensitive muscarinic K+ (KACh) channel by use of the patch-clamp technique. In isolated guinea pig atrial cells, IK.ACh was activated by extracellular application of carbachol (1 microM) or adenosine (10 microM) or by the intracellular loading of GTP gamma S (100 microM). Amiodarone inhibited the IK.ACh activated in these three different ways with similar IC50 values around 2 microM, which indicated that amiodarone directly depresses the function of the KACh channel itself and/or GTP-binding proteins. Single KACh channel current was also recorded by use of a pipette solution containing carbachol (1 microM) or atropine (10 microM) plus theophylline (100 microM) in a cell-attached configuration. Amiodarone at a concentration of 3 microM significantly decreased the open probability of the KACh channel in both conditions. Amiodarone also reversed the carbachol- and adenosine-induced action potential shortening in a concentration-dependent manner. In isolated guinea pig hearts, perfusion of 1 microM carbachol shortened the effective refractory period of the atria and lowered the atrial fibrillation threshold. Addition of 10 microM amiodarone reversed these electrophysiological parameters to the control level. These results suggest that amiodarone inhibits IK.ACh by depressing the function of the KACh channel itself and/or associated GTP-binding proteins. This effect of amiodarone may at least in part be involved in the antiarrhythmic action against atrial fibrillation.
众所周知,胺碘酮对心房颤动的治疗有效。然而,胺碘酮对毒蕈碱型乙酰胆碱受体介导的钾电流(IK.ACh)的影响尚未得到评估,而该电流在心房动作电位复极化过程中起重要作用。本研究旨在利用膜片钳技术确定胺碘酮是否抑制乙酰胆碱敏感的毒蕈碱钾(KACh)通道。在分离的豚鼠心房细胞中,IK.ACh可通过细胞外施加卡巴胆碱(1微摩尔)或腺苷(10微摩尔)或通过细胞内加载GTPγS(100微摩尔)来激活。胺碘酮以相似的IC50值(约2微摩尔)抑制以这三种不同方式激活的IK.ACh,这表明胺碘酮直接抑制KACh通道本身和/或GTP结合蛋白的功能。还采用细胞贴附式记录模式,使用含有卡巴胆碱(1微摩尔)或阿托品(10微摩尔)加茶碱(100微摩尔)的移液管溶液记录单个KACh通道电流。在两种情况下,3微摩尔浓度的胺碘酮均显著降低KACh通道的开放概率。胺碘酮还以浓度依赖的方式逆转卡巴胆碱和腺苷诱导的动作电位缩短。在分离的豚鼠心脏中,灌注1微摩尔卡巴胆碱可缩短心房的有效不应期并降低心房颤动阈值。加入10微摩尔胺碘酮可将这些电生理参数恢复至对照水平。这些结果表明,胺碘酮通过抑制KACh通道本身和/或相关GTP结合蛋白的功能来抑制IK.ACh。胺碘酮的这种作用可能至少部分参与了其对心房颤动的抗心律失常作用。